目的制备酒石酸托特罗定渗透泵片，考察其体外释药特性。
OBJECTIVE to prepare the tolterodine osmotic pump tablet and study its release profiles in vitro.
目的制备酒石酸托特罗定滴丸，考察其体外溶出特性及基质对滴丸外观性状和溶出度的影响。
Objective To prepare Tolterodine Tartrate Pills (TTP), study the character of its dissolubility, and the influence of the base on appearance, characteristics and dissolubility.
结论琥珀酸索利那新治疗OAB较托特罗定有更好的效果和更高的安全性，琥珀酸索利那新将可能成为治疗OAB的首选药物。
Conclusions Solifenacin vesicare is a safer and more effective drug over tolterodine for the treatment of patients with OAB, and it could be served as a drug of first choice for treating OAB.
结论琥珀酸索利那新治疗OAB较托特罗定有更好的效果和更高的安全性，琥珀酸索利那新将可能成为治疗OAB的首选药物。
Conclusions Solifenacin vesicare is a safer and more effective drug over tolterodine for the treatment of patients with OAB, and it could be served as a drug of first choice for treating OAB.
应用推荐